Latest filing published 24 Aug 2026 for Replimune Group, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Philip Astley-Sparke: trading record in brief
Filings by Philip Astley-Sparke span 2 companies, the busiest being Replimune Group, Inc. and uniQure N.V. Between 26 January 2018 and 20 August 2026, the trades on record add up to 51 filings.
No open-market purchase appears, only 40 sales worth €7.2M. Besides market trades, the filings include 8 share grants.
The latest filing, published on 24 August 2026, reports a transaction in Replimune Group, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Philip Astley-Sparke
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0001104659-26-100437:0
- 50,000 shares0Common StockSEC:0001104659-26-040577:0
- 25,000 shares0Common StockSEC:0001104659-26-018159:0
- 32,279 shares@ US$8.0625.9% of flowCommon StockSEC:0001104659-25-052147:0
- 50,000 shares0Common StockSEC:0001104659-24-095834:0
- 37,928 shares@ US$6.4725.4% of flowCommon StockSEC:0001104659-24-063561:0
- 17,902 shares@ US$18.0533.5% of flowCommon StockSEC:0001104659-23-062370:0
- 142,100 shares0Common StockSEC:0001104659-23-041717:0
- 9,632 shares@ US$14.5915.2% of flowCommon StockSEC:0001104659-22-062605:0
- 70,000 shares0Common StockSEC:0001104659-22-042773:0
10 of 10 declarations
